z-logo
Premium
Functional characterization of new allelic polymorphisms identified in the promoter region of the human M x A gene
Author(s) -
Tran Thi Duc T.,
Desmecht D.,
Cornet A.
Publication year - 2013
Publication title -
international journal of immunogenetics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.41
H-Index - 47
eISSN - 1744-313X
pISSN - 1744-3121
DOI - 10.1111/j.1744-313x.2012.01153.x
Subject(s) - biology , gene , allele , promoter , genetics , gene isoform , innate immune system , effector , transcription (linguistics) , rna , gene expression , reporter gene , microbiology and biotechnology , immune system , linguistics , philosophy
Summary The M x proteins are high‐molecular‐weight dynamin‐like proteins whose expression depends strictly on type‐ I and type‐ III interferons ( IFN ). Some isoforms are able to inhibit the life cycle of one or several viruses and are thus components of innate immune response. The human M x A protein displays the broadest antiviral spectrum which makes it appear as a key antiviral effector of innate immunity. Allelic polymorphisms located in the M x A gene promoter can be expected to affect the magnitude of M x A m RNA transcription in response to IFN s and therefore to alter the severity of viral diseases in humans. Here, three single nucleotide polymorphism sites (−309, −101 and +20) were examined for their ability to alter M x A gene promoter‐driven reporter expression. We show that, besides the previously reported role of −123 A and −88 T , the presence of ‐101 G is equally important. Moreover, when a promoter construct carries these three critical nucleotides, a first additional positive effect is conferred by a C at position −309 and, in this latter case, a second additional effect is produced by a A at position +20. This finding is clinically useful to improve prediction of IFN ‐responsiveness in patients not only with viral diseases for which type‐ I IFN therapy is used.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom